Promising new research in battle against kidney cancer


Kidney cancer is one of the ten most common cancers in both men and women.

According to the American Cancer Society, more than 62,000 people in the United States will be diagnosed with kidney cancer this year. It typically strikes those around the age of 64, with renal cell carcinoma (RCC) being the most common type.

Dr. Robert Figlin with the Cancer Institute at Cedars-Sinai Medical Center in Los Angeles told California Life kidney cancer is especially dangerous because it’s hard to detect.

“It can exist for months to years prior to diagnosis,” Figlin said.

Risk factors for kidney cancer include obesity, smoking, workplace exposures and certain genetic disorders, and men seem to be more susceptible than women.

There is some good news. New research presented at the annual meeting of the American Society of Clinical Oncology shows there are new treatments to target kidney cancer.

To learn more, check out our story below, airing statewide this week on California Life.